Virology
A plethora of papillomaviruses
By Vincent Racaniello | | Information
When Harald zur Hausen identified the first human papillomavirus (HPV-16) in 1983 in women with cervical cancer, little did he know he would receive the Nobel Prize in Medicine for this discovery 25 years later. He probably also did not know how difficult it would be to propagate these viruses in a way that would allow …
Dreaming of inactivated poliovirus vaccine
By Vincent Racaniello | | Commentary
The World Health Organization’s global polio eradication effort uses the live, attenuated poliovirus vaccines developed by Albert Sabin. When the eradication program was announced in 1988, the goal was to eliminate global poliomyelitis, then cease immunization with poliovirus at some point in the future. In 2002 an outbreak of polio in the Dominican Republic sent …
Influenza vaccine for life?
By Vincent Racaniello | | Information
The best way to prevent influenza is by immunization. Unlike vaccines for polio and measles, which confer life-long immunity, the influenza vaccine protects for only one year. Influenza virus undergoes antigenic variation, necessitating annual production of a new vaccine. Is it possible to formulate an influenza vaccine that protects against all virus strains for life? Two studies …
Anti-HIV ribozyme: an alternative to HAART?
By Vincent Racaniello | | Information
The treatment of AIDS patients with a combination of three or four antiviral drugs is known as HAART, or highly active antiretroviral therapy. Combination therapy has been effective for long-term control of infection, and represents one of the high points in AIDS research. The downside of HAART is that strict adherence to daily therapy must …
What color is a virus?
By Vincent Racaniello | | Information
The Nobel Prize in Chemistry for 2008 was awarded to Osamu Shimomura, Martin Chalfie, and Roger Y. Tsien for the discovery and development of the green fluorescent protein, GFP. Dr. Chalfie’s contribution was to show that GFP could be used as a genetic tag by producing the protein in the transparent roundworm Caenorhabditis elegans. Who …
TWiV #21: Viruses of bacteria
By Vincent Racaniello | | Information
In episode #21 of This Week in Virology, Vincent, Dick, and Alan are joined by Max Gottesman, who has researched viruses of bacteria – bacteriophages – for many years. They discuss an unusual wasp-virus symbiosis, influenza transmission and absolute humidity, how mosquitoes survive Dengue virus infection, and bacteriophages. Click the arrow above to play, or …
David Tuller
Trial By Error: Is Professor Crawley Retired from Bristol, or Isn’t She?
By David Tuller, DrPH Professor Esther Crawley, the methodologically and ethically challenged pediatrician and former grant queen at the University of Bristol, retired from medical practice and, apparently, from academia at some point in the recent past. So why does her name still appear on websites as if she were an active participant in research …
Trial By Error: Is Professor Crawley Retired from Bristol, or Isn’t She? Read More »
Trial By Error: Norway Disability Case Exposes Flaws in Draft Guideline for “Long-Term Fatigue–including ME/CFS”
By David Tuller, DrPH A recent disability case in Norway provides a good example of why the draft of a new guideline for “long-term fatigue—including ME/CFS” is so problematic. As I reported last week, the draft guideline, produced by the Norwegian Directorate of Health*, generally favors the biopsychosocial approach. The guideline offers few specifics about …
Trial By Error: Why is Professor Crawley Still on the COFFI Steering Committee?
By David Tuller, DrPH Several years ago, the leaders of the biopsychosocial ideological brigades decided to create the Collaborative On Fatigue and related symptoms Following Infection, or COFFI. According to its website, COFFI’s “overarching aim” is “to investigate factors influencing the development of long-term symptoms (in particular fatigue) following certain infectious diseases.” Akershus University Hospital …
Trial By Error: Why is Professor Crawley Still on the COFFI Steering Committee? Read More »
Trial By Error: Aussie GPs Still Push Graded Exercise Therapy
By David Tuller, DrPH When I was in Australia for the first time in 2018, it was clear that the country’s general practitioners were fervent supporters of the biopsychosocial ideology when it came to ME/CFS. That hasn’t changed, according to a recent exchange of views published in the Australian Journal of General Practice. The debate …
Trial By Error: Aussie GPs Still Push Graded Exercise Therapy Read More »
Trial By Error: Dutch Agency Funds CBT Training Program Based on Flawed Long COVID Trial
By David Tuller, DrPH Here is how bullshit replicates itself in today’s medical world: Conduct a flawed trial, declare success despite serious questions, then develop health policy based on these hyped-up claims. ZonMW, a major Dutch healthcare funding agency, is supporting a new program led by Professor Hans Knoop, a longtime supporter of the fraudulent …
Trial By Error: Dutch Agency Funds CBT Training Program Based on Flawed Long COVID Trial Read More »
Trial By Error: More on Norway’s Problematic Draft Guideline for “Long-Term Fatigue–including ME/CFS”
By David Tuller, DrPH I posted a piece yesterday on Norway’s draft guideline for “long-term fatigue—including ME/CFS.” But my post was already outdated! The draft guideline was written by a team from the Norwegian Directorate of Health and is open for public comment until May 4th. A working group of 25 individuals from a range …